Emergent Biosolutions Inc (EBS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Emergent Biosolutions Inc   (NYSE: EBS)
 

Emergent Biosolutions Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Emergent Biosolutions Inc inventory turnover ratio, the Emergent Biosolutions Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.02 in the second quarter 2026, yet the ratio remained below the average, as EBS's market remain challenging.Average inventory processing period, for the Emergent Biosolutions Inc in Jun 30 2026 quarter, has decreased to 358 days, compare to 401 days, in the Mar 31 2026 quarter.

Within Healthcare sector 310 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1841, from total ranking in the first quarter 2026 at 2062.

EBS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Emergent Biosolutions Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EBS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -10.34 % 4.33 % 10.17 % 10.41 % 6.65 %
Y / Y Cost of Sales Growth 45.14 % -18.64 % -28.05 % -29.93 % -77.41 %
Inventory Turnover Ratio (TTM) 1.02 0.91 0.96 1.09 1.23
EBS's Total Ranking # 1841 # 2062 # 1859 # 1837 # 1595
Average inventory processing period 357 402 378 335 297
Seq. Inventory Growth -7.33 % -4.6 % -3.62 % 5.23 % 7.83 %
Seq. Cost of Sales Growth 34.86 % -15.19 % -1.16 % 28.4 % -24.41 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 91
Healthcare Sector # 311
Overall Market # 1841

Inventory Turnover Ratio Statistics
High Average Low
3.21 1.83 0.71
(Dec 31 2013)   (Sep 30 2022)



EBS Company Profile >> Back to EBS Efficiency Comparisons >> Compare EBS Inventory Turnover Ratio to its Competitors

Financial Statements
Emergent Biosolutions Inc 's Inventories $ 304 Millions Visit EBS's Balance sheet
Emergent Biosolutions Inc 's Cost of Revenues TTM $ 340 Millions Visit EBS's Income Statement
What are EBS's Sales? Visit EBS's Sales by Segment

Other Inventory Turnover Ratios
Emergent Biosolutions Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EBS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EBS's Competitors
Inventory Turnover Ratio for EBS's Suppliers
Inventory Turnover Ratio for EBS's Customers

You may also want to know
EBS's Sales Growth Rates EBS's Pe Price to earnings ratio EBS's Receivables Turnover Ratio EBS's Stock Quote
EBS's Net Income Growth Rates EBS's Ps Price to Sales ratio EBS's Sales per Employee EBS's Asset Turnover Ratio
EBS's Net Margin EBS's Pb Price to Book ratio EBS's Financial Strength Ratios EBS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Akebia Therapeutics Inc   2.96 $ 44.632  Millions$ 15  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Iovance Biotherapeutics inc   2.81 $ 152.872  Millions$ 54  Millions
Livanova Plc  2.79 $ 468.065  Millions$ 168  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Dentsply Sirona Inc   2.77 $ 1,839.000  Millions$ 663  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions
IMPACT BIOMEDICAL INC.  2.46 $ 0.414  Millions$ 0  Millions
Quidelortho Corp  2.45 $ 1,481.500  Millions$ 605  Millions
Perrigo Company Plc  2.43 $ 2,775.900  Millions$ 1,140  Millions
Pro dex Inc   2.43 $ 53.213  Millions$ 22  Millions
Angiodynamics Inc   2.43 $ 142.834  Millions$ 59  Millions
Cytosorbents Corporation  2.43 $ 10.584  Millions$ 4  Millions
Journey Medical Corp  2.42 $ 23.556  Millions$ 10  Millions
Aquestive Therapeutics Inc   2.42 $ 17.828  Millions$ 7  Millions
Viatris Inc   2.41 $ 9,604.200  Millions$ 3,993  Millions
Electrocore Inc   2.40 $ 4.346  Millions$ 2  Millions
Cannapharmarx Inc   2.37 $ 2.483  Millions$ 1  Millions
Aurinia Pharmaceuticals Inc   2.34 $ 30.036  Millions$ 13  Millions

Date modified: 2026-09-08T01:14:04+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.